Drug
Enarodustat
Enarodustat is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph phase_4
1
33%
Ph phase_3
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
2(66.7%)
Phase 4Post-market surveillance
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Not yet recruiting2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 32 (66.7%)
Phase 41 (33.3%)
Trials by Status
not_yet_recruiting267%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
not_yet_recruitingphase_3
Enarodustat + CsA vs CsA in Newly Diagnosed TD-NSAA
NCT07548671
not_yet_recruitingphase_3
Enarodustat+CsA vs CsA in the Treatment of Newly-diagnosed TD-NSAA
NCT07522996
recruitingphase_4
Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease
NCT06725810
Clinical Trials (3)
Showing 3 of 3 trials
NCT07548671Phase 3
Enarodustat + CsA vs CsA in Newly Diagnosed TD-NSAA
NCT07522996Phase 3
Enarodustat+CsA vs CsA in the Treatment of Newly-diagnosed TD-NSAA
NCT06725810Phase 4
Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3